# FDA Inspection 1202885 - Novartis Singapore Pharmaceutical Manufacturing Pte. - March 03, 2023

Source: https://www.keypedia.com/records/fda_inspections/novartis-singapore-pharmaceutical-manufacturing-pte/867d6c5c-4948-4698-82d2-787effd04fbc
Source feed: FDA_Inspections

> FDA Inspection 1202885 for Novartis Singapore Pharmaceutical Manufacturing Pte. on March 03, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1202885
- Company Name: Novartis Singapore Pharmaceutical Manufacturing Pte.
- Inspection Date: 2023-03-03
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/novartis-singapore-pharmaceutical-manufacturing-pte/fb15a25e-3d5c-408e-92a9-ba4b0906f449

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c